Certolizumab pegol for treating moderate to severe plaque psoriasis

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers  (PDF 16.28 MB)

  Published:

  17 April 2019

• Final appraisal determination committee papers (PDF 1.96 MB)

  Published:

  17 April 2019